Optibiotix Health Plc

Company Profile

Company website
Pharmaceuticals & Biotechnology (Biotechnology)

OptiBiotix Health plc (AIM: OPTI) develops compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.

Investor Access

17 Nov
Event information

Management will hold a presentation for Investors through the digital platform, Investor Meet Company, on Thursday, 17 November 2022 at 12:00 providing an update on the commercial strategy and future plans for the Company. Investors can sign up to Investor Meet Company for free, by clicking here.

Thursday, 17 November 2022 at 12:00
Financial Calendar
 Event  Date
Year End 31 December
Half  Year End 30 June
Preliminary Results* May
Interim Results* September
AGM* July

* Months based on previous announcements of this kind